D-Wave Quantum falls nearly 3% as earnings miss overshadows revenue beat
Investing.com - Biomea Fusion reported on Monday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Biomea Fusion announced earnings per share of $-0.78 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.64 on revenue of $0.00.
Biomea Fusion 's are up 100% and is trading at $10.07 , still down 29.08% from its 52 week high of $14.20 set on Tuesday, August 16, 2022.
Biomea Fusion follows other major Healthcare sector earnings this month
Biomea Fusion's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar